Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-11

Clinical Trial Update: Bruxism Xeomin® Intervention Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a Xeomin intervention targeting sleep bruxism in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Dominik Ettlin | Conditions: Sleep Bruxism, Adult | Phase 4 | Status: UNKNOWN